WGS - NASDAQ

GeneDx Holdings Corp.

WGS·NASDAQ

$56.27

+6.1%

HealthcareMedical - Healthcare Information Services

GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$1.67B

EPS-0.7300

P/E Ratio-77.08

Earnings Date08/04/2026

wgs

Income Before Tax

Last Annual Value

-21.14M

3-Year CAGR

67%

5-Year CAGR

39%

10-Year CAGR

Adjust for Inflation

GeneDx Holdings Corp. Competitors Analysis of Income Before Tax

WGS · NASDAQ

Company	Income Before Tax	CAGR 3Y	CAGR 5Y	CAGR 10Y
GeneDx Holdings Corp. NASDAQ:WGS	-21.14M	N/A	N/A	N/A
Privia Health Group, Inc. NASDAQ:PRVA	43.94M	14.8%	N/A	N/A
NewAmsterdam Pharma Company N.V. NASDAQ:NAMS	-203.82M	N/A	N/A	N/A
Kymera Therapeutics, Inc. NASDAQ:KYMR	-311.62M	N/A	N/A	N/A
Hinge Health, Inc. NYSE:HNGE	-527.26M	N/A	N/A	N/A
Viking Therapeutics, Inc. NASDAQ:VKTX	-359.64M	N/A	N/A	N/A
Oscar Health, Inc. NYSE:OSCR	-437.30M	N/A	N/A	N/A
Immunovant, Inc. NASDAQ:IMVT	-505.39M	N/A	N/A	N/A
TransMedics Group, Inc. NASDAQ:TMDX	107.52M	N/A	N/A	N/A
Crinetics Pharmaceuticals, Inc. NASDAQ:CRNX	-465.14M	N/A	N/A	N/A
Option Care Health, Inc. NASDAQ:OPCH	282.90M	-7.6%	19.4%	N/A

GeneDx Holdings Corp. Fair Value Envelope

WGS · NASDAQ

Our analysis suggests that WGS has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $56.27, this represents a potential HIDDEN relative to our calculated worth for GeneDx Holdings Corp..

HIDDEN

Intrinsic Value

Current Price: $56.27

Related Guides

Blog Categories

Continue your WGS research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.